MultiCell Technologies, Inc.
MCET - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$50.01K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $50,009.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | -8.86 |
| Outstanding Shares | 5,000,948 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.1 |
|---|---|
| PEG | 0.06 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About MultiCell Technologies, Inc.
2 employees
CEO: W. Gerald Newmin
MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm, primarily focused on the creation of innovative therapeutic agents and research tools. Their efforts are directed towards addressing a range of medical challenges,...